BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 8073481)

  • 1. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
    Shulman IA; Calderon C; Nelson JM; Nakayama R
    Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
    Rushin J; Rumsey DH; Ewing CA; Sandler SG
    Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
    Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
    Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
    Judd WJ; Moulds M; Schlanser G
    Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-G in a pregnant patient.
    Cash K; Brown T; Strupp A; Uehlinger J
    Transfusion; 1999 May; 39(5):531-3. PubMed ID: 10336005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A MAR-like antibody in a DCWe/DCWe person.
    O'Shea KP; Oyen R; Sausais L; Stephens VA; Stillwell GF; Bisgard LA; Martin J; Reid ME
    Transfusion; 2001 Jan; 41(1):53-5. PubMed ID: 11161245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel method using formamide for the elution of antibodies from erythrocytes.
    Caruccio L; Byrne K; Procter J; Stroncek D
    Vox Sang; 2002 Jul; 83(1):63-9. PubMed ID: 12100391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices.
    Lu W; Stephens L; Shmookler A; O'Brien K; Karp JK; Hermelin D; Bakhtary S; Almozain N; George M; Fung M
    Transfusion; 2024 May; 64(5):839-845. PubMed ID: 38534065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Rh alloimmunization after trauma resuscitation.
    Williams LA; Sikora J; Aldrees R; Pham HP; Marques MB
    Transfus Apher Sci; 2019 Dec; 58(6):102652. PubMed ID: 31672466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D.
    Kumpel BM
    Transfusion; 2001 Aug; 41(8):1059-63. PubMed ID: 11493739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.
    Zwiers C; Koelewijn JM; Vermij L; van Sambeeck J; Oepkes D; de Haas M; van der Schoot CE
    Transfusion; 2018 Jul; 58(7):1611-1617. PubMed ID: 29624682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of unexpected red blood cell antibodies among pregnant women in Uganda.
    Eipl K; Nakabiito C; Bwogi K; Motevalli M; Roots A; Blagg L; Jackson JB
    Immunohematology; 2012; 28(4):115-7. PubMed ID: 23421539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiidiotypic IgG crossreactive with Rh alloantibodies in red cell autoimmunity.
    Masouredis SP; Branks MJ; Victoria EJ
    Blood; 1987 Sep; 70(3):710-5. PubMed ID: 3113514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of Rh alloimmunization. Fact or fancy?
    Bowman JM; Pollock JM
    Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient with anti-f in India identified by extensive immunohematologic workup.
    Golia S; Pawar S; Tiwari AK; Aggarwal G; Singh N; Gupta S
    Immunohematology; 2024 Jun; 40(2):54-57. PubMed ID: 38910446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive anti-C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series.
    Sostin N; Ross R; Balbuena-Merle R; Hendrickson JE; Tormey CA
    J Clin Apher; 2020 Jun; 35(3):224-226. PubMed ID: 32110829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.